Back to Market Feed

Historical record - last NADAC effective date: 4/17/2024

Product Information

HM NAPROXEN SODIUM 220 MG CAP is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1549 per EA under NDC 62011036901. Its NADAC has been published 251 times since Jul 17, 2019.

FDA first approved this application on Mar 15, 2018.

HM NAPROXEN SODIUM 220 MG CAP

Naproxen Sodium
$0.1549per EA
OTC

Strength

220 mg/1

NDC

62011036901

Classification

Generic

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Effective Date

4/17/2024

Active Ingredients

NAPROXEN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA208363

FDA Approved

3/15/2018

On Market Since

4/1/2018

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for HM NAPROXEN SODIUM 220 MG CAP has been published 251 times since Jul 17, 2019, and over the history we have for it it has risen 7.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1549 per EA
All-time high$0.1734 (Dec 13, 2023)
All-time low$0.1374 (Dec 22, 2021)
Median price$0.1457
Average price$0.1466
Largest weekly change-12.1% (Dec 20, 2023)
Weeks tracked251
Tracking sinceJul 17, 2019

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-1.3%

5Y

+12.5%

All

+7.1%

Last surveyed May 1, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Naproxen Sodium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

MINIPRIN EC 81 MG TABLET
Generic
49483033010•Time-Cap Labs Inc.
$0.0118
per EA
MINIPRIN EC 81 MG TABLET
Generic
49483033012•Time-Cap Labs Inc.
$0.0118
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035203•Chain Drug Marketing Association
$0.0121
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035210•Chain Drug Marketing Association
$0.0121
per EA
ST. JOSEPH ASPIRIN EC 81 MG TB
Generic
69536018112•Foundation Consumer Healthcare LLC
$0.0139
per EA
ASPIRIN EC 81 MG TABLET
Generic
00536123441•Rugby Laboratories
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904675180•Major Pharmaceuticals
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904678370•Major Pharmaceuticals
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059848•AmerisourceBergen
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059887•AmerisourceBergen
$0.0146
per EA

Frequently asked questions

What is the NADAC price of HM NAPROXEN SODIUM 220 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for HM NAPROXEN SODIUM 220 MG CAP, manufactured by Strategic Sourcing Services LLC, is $0.1549 per EA (NDC 62011036901), effective May 1, 2024.

How has the price of HM NAPROXEN SODIUM 220 MG CAP changed over time?

Over the history we have for it, the NADAC for HM NAPROXEN SODIUM 220 MG CAP has risen 7.1%. It has been tracked across 251 weekly CMS publications since Jul 17, 2019.

What are the highest and lowest recorded NADAC prices for HM NAPROXEN SODIUM 220 MG CAP?

Since Jul 17, 2019, the NADAC for HM NAPROXEN SODIUM 220 MG CAP has ranged from a low of $0.1374 (Dec 22, 2021) to a high of $0.1734 (Dec 13, 2023), with a median of $0.1457 per EA.

Are there cheaper alternatives to HM NAPROXEN SODIUM 220 MG CAP?

No other NADAC-published product currently shares the active ingredient and strength of HM NAPROXEN SODIUM 220 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures HM NAPROXEN SODIUM 220 MG CAP?

HM NAPROXEN SODIUM 220 MG CAP (NDC 62011036901) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.